FFM
EW icon

Fisher Funds Management’s Edwards Lifesciences EW Stock Holding History

Fisher Funds Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36M Sell
397,646
-121,948
-23% -$10.2M 1.02% 25
2026
Q1 		$41.6M Sell
519,594
-242,305
-32% -$20M 1.22% 25
2025
Q4 		$65.1M Sell
761,899
-125,697
-14% -$10.3M 1.68% 16
2025
Q3 		$69M Sell
887,596
-60,565
-6% -$4.73M 1.82% 16
2025
Q2 		$74.2M Buy
948,161
+115,686
+14% +$8.63M 1.76% 15
2025
Q1 		$60.3M Sell
832,475
-122,625
-13% -$8.78M 1.46% 21
2024
Q4 		$70.7M Buy
+955,100
New +$66.8M 1.71% 18

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $1.85B AUM 62.46% 1-Year Est. Return
PTPFOECYE
PBU - The Pension Fund of Early Childhood & Youth Educators Copenhagen $4.42B AUM

Fisher Funds Management's EW Position: Q2 2026 in Review

Fisher Funds Management reduced its Edwards Lifesciences (EW) stake by 23% in Q2 2026, selling an estimated $10.2M and leaving 397,646 shares worth $36M. The position accounts for 1.02% of the portfolio, ranked #25.

Fisher Funds Management first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $74.2M in Q2 2025. 195 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Fisher Funds Management held 397,646 shares of Edwards Lifesciences worth $36M as of Q2 2026.
  • Fisher Funds Management sold 121,948 Edwards Lifesciences shares in Q2 2026, an estimated $10.2M.
  • Edwards Lifesciences made up 1.02% of Fisher Funds Management's portfolio in Q2 2026, its #25 holding.
  • Fisher Funds Management first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • Fisher Funds Management's Edwards Lifesciences position peaked at $74.2M in Q2 2025.
  • 195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Fisher Funds Management's 13F filing for Q2 2026, filed 14 Jul 2026.